Literature DB >> 4339927

Bone scanning. Its value in the preoperative evaluation of patients with suspicious breast masses.

H C Hoffman, R Marty.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4339927     DOI: 10.1016/0002-9610(72)90013-x

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


× No keyword cloud information.
  9 in total

1.  Radiology: bone scanning in the staging of breast cancer.

Authors:  N Chafetz; W Hooser
Journal:  West J Med       Date:  1977-03

2.  Nononcologic disease in patients with cancer.

Authors:  B B Lowitz; R S Benjamin
Journal:  West J Med       Date:  1977-07

3.  An evaluation of bone scans as screening procedures for occult metastases in primary breast cancer.

Authors:  R R Baker; E R Holmes; P O Alderson; N F Khouri; H N Wagner
Journal:  Ann Surg       Date:  1977-09       Impact factor: 12.969

4.  The value of whole body bone scan in the pre-operative assessment in carcinoma of the breast.

Authors:  P Hahn; K J Vikterlöf; H Rydman; K W Beckman; O Blom
Journal:  Eur J Nucl Med       Date:  1979-06-01

5.  Baseline staging tests in primary breast cancer: a practice guideline.

Authors:  R E Myers; M Johnston; K Pritchard; M Levine; T Oliver
Journal:  CMAJ       Date:  2001-05-15       Impact factor: 8.262

6.  Routine bone scanning in patients with T1 and T2 breast cancer: a waste of money.

Authors:  K A Yeh; L Fortunato; J A Ridge; J P Hoffman; B L Eisenberg; E R Sigurdson
Journal:  Ann Surg Oncol       Date:  1995-07       Impact factor: 5.344

7.  Late bone metastasis in breast carcinoma.

Authors:  V Lopez-Majano; P Sobti; J Layon
Journal:  Eur J Nucl Med       Date:  1983

8.  Radionuclide evaluation of skeletal metastases: practical considerations.

Authors:  R H Gold; L W Bassett
Journal:  Skeletal Radiol       Date:  1986       Impact factor: 2.199

9.  Estrogens and antiestrogens stimulate release of bone resorbing activity by cultured human breast cancer cells.

Authors:  A Valentin-Opran; G Eilon; S Saez; G R Mundy
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.